Macrophage colony-stimulating factor inhibits tumor necrosis factor production and prolongs skin graft survival

Transplantation. 2004 Feb 15;77(3):456-59. doi: 10.1097/01.TP.0000100483.41935.B5.

Abstract

Background: Despite the availability of a variety of immunosuppressive agents, acute rejection and infection after organ transplantation remain serious problems.

Methods and results: We examined the effect of macrophage colony-stimulating factor (M-CSF) on the production of tumor necrosis factor (TNF) in a Bacille de Calmette Guérin-lipopolysaccharide-challenged mouse model. Both serial and repeated injections of M-CSF inhibited TNF production in a dose-dependent manner. Electrophoretic mobility shift assay showed that M-CSF-induced inhibition of TNF production was a result of suppression of nuclear factor-kappaB. High-dose M-CSF significantly prolonged skin graft survival in mice with orthotopic transplantation compared with the control and low-dose M-CSF groups. The combined administration of low-dose M-CSF and cyclosporine also significantly prolonged graft survival compared with the control and low-dose single agent-treated groups.

Conclusions: Our results indicate that M-CSF at a high dose is a potent inhibitor of cytokine production and can potentially be used as an immunosuppressive agent for allograft rejection.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Dose-Response Relationship, Drug
  • Graft Survival / drug effects*
  • Humans
  • Immunosuppressive Agents / administration & dosage
  • Immunosuppressive Agents / pharmacology*
  • Injections, Intravenous
  • Lipopolysaccharides / pharmacology
  • Macrophage Colony-Stimulating Factor / administration & dosage
  • Macrophage Colony-Stimulating Factor / pharmacology*
  • Male
  • Mice
  • Mice, Inbred C57BL
  • Mycobacterium bovis / metabolism
  • Recombinant Proteins / administration & dosage
  • Recombinant Proteins / pharmacology
  • Skin Transplantation*
  • Tumor Necrosis Factor-alpha / antagonists & inhibitors*

Substances

  • Immunosuppressive Agents
  • Lipopolysaccharides
  • Recombinant Proteins
  • Tumor Necrosis Factor-alpha
  • Macrophage Colony-Stimulating Factor